This inventor holds 6 USPTO granted patents and 10 published patent applications and 1 EPO patent. Top assignees: Advaxis, Inc., Merck Sharp + Dohme Corp.. Active years: 2018-2024.
Location History:
- Newton, PA (US) (2021)
- Newtown, PA (US) (2018 - 2024)
Company Filing History:
6 out of 20 
1 out of 2,405 
Years Active: 2018-2024
Title: Innovations by Robert Petit in Cancer Treatment
Introduction
Robert Petit is an accomplished inventor based in Newtown, PA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 6 patents to his name, Petit has focused on creating immunogenic compositions and methods that target recurrent cancer mutations.
Latest Patents
One of his latest patents is titled "Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof." This patent describes recombinant fusion polypeptides that include one or more antigenic peptides from cancer-associated proteins. These compositions aim to induce an immune response against tumors by utilizing various antigenic peptides, including those that comprise recurrent cancer mutations. Additionally, Petit has developed methods for generating these fusion polypeptides, as well as immunogenic compositions, pharmaceutical compositions, and vaccines that can be used in treating or preventing cancer.
Another notable patent is "Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof." This disclosure provides delivery vectors that include minigene expression constructs. These constructs are designed to induce an immune response against tumors and can be used for vaccination purposes in subjects with antigen-expressing tumors.
Career Highlights
Throughout his career, Robert Petit has worked with prominent companies in the pharmaceutical and biotechnology sectors. He has been associated with Advaxis, Inc. and Merck Sharp & Dohme Corp., where he has contributed to the advancement of cancer therapies. His work has been instrumental in developing innovative solutions that address critical challenges in cancer treatment.
Collaborations
Robert Petit has collaborated with notable professionals in his field, including Michael F. Princiotta and David J. Mauro. These collaborations have further enhanced his research and development efforts, leading to impactful innovations in cancer therapy.
Conclusion
Robert Petit is a pioneering inventor whose work in cancer treatment has the potential to change the landscape of oncology. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.